Evaluation of a proposed link between the SARS-CoV-2 furin cleavage site and mouse-adapted MERS-coronavirus MA30

S Sarah M. Metzger (Institute of Virology, Charité—Universitätsmedizin Berlin, Corporate Member of Freie Universität and Humboldt-Universität Berlin) T Terry C. Jones J Jenny I. J. Meier (Institute of Virology, Charité—Universitätsmedizin Berlin, Corporate Member of Freie Universität and Humboldt-Universität Berlin) A Anja Richter (Institute of Virology, Charité—Universitätsmedizin Berlin, Corporate Member of Freie Universität and Humboldt-Universität Berlin) M Mark-Christian Klassen (Leibniz Research Laboratories for Biotechnology and Artificial Organs and National Center for Lung Research, Hannover Medical School) R Ruth Olmer (Leibniz Research Laboratories for Biotechnology and Artificial Organs and National Center for Lung Research, Hannover Medical School) N Nicolai Diegmüller (Institute of Virology, Charité—Universitätsmedizin Berlin, Corporate Member of Freie Universität and Humboldt-Universität Berlin) K Kim C. Heimsch (Institute of Virology, Charité—Universitätsmedizin Berlin, Corporate Member of Freie Universität and Humboldt-Universität Berlin) C Christian Drosten

Abstract

The origin of the polybasic furin cleavage site (FCS) of SARS-CoV-2 remains a central question in debates on the emergence of COVID-19. One hypothesis proposes a genetic relationship between the SARS-CoV-2 S1/S2 motif RRAR and the RRVR sequence found in the mouse-adapted MERS-CoV strain MERS-MA30. Here, we combined large-scale bioinformatic analysis with experimental virology to evaluate this scenario. Analysis of over 17 million SARS-CoV-2 genomes revealed that the S:684V substitution corresponding to RRVR occurred repeatedly but only sporadically, never became phylogenetically basal, and showed limited geographic and temporal spread. Using reverse genetics, we generated SARS-CoV-2 variants encoding RRVR and demonstrated that S:684V consistently reduced viral entry efficiency and competitive fitness in multiple cell systems, including human respiratory epithelial cultures. RRVR variants did not evolve toward RRAR but instead accumulated alternative substitutions. These findings do not support an evolutionary relationship between MERS-MA30 and the SARS-CoV-2 FCS.

Article Details

Volume / Issue Vol. 123, Issue 27
Published July 07, 2026
ISSN 0027-8424
Publisher National Academy of Sciences

Authors (9)

S

Sarah M. Metzger

Institute of Virology, Charité—Universitätsmedizin Berlin, Corporate Member of Freie Universität and Humboldt-Universität Berlin

T

Terry C. Jones

J

Jenny I. J. Meier

Institute of Virology, Charité—Universitätsmedizin Berlin, Corporate Member of Freie Universität and Humboldt-Universität Berlin

A

Anja Richter

Institute of Virology, Charité—Universitätsmedizin Berlin, Corporate Member of Freie Universität and Humboldt-Universität Berlin

M

Mark-Christian Klassen

Leibniz Research Laboratories for Biotechnology and Artificial Organs and National Center for Lung Research, Hannover Medical School

R

Ruth Olmer

Leibniz Research Laboratories for Biotechnology and Artificial Organs and National Center for Lung Research, Hannover Medical School

N

Nicolai Diegmüller

Institute of Virology, Charité—Universitätsmedizin Berlin, Corporate Member of Freie Universität and Humboldt-Universität Berlin

K

Kim C. Heimsch

Institute of Virology, Charité—Universitätsmedizin Berlin, Corporate Member of Freie Universität and Humboldt-Universität Berlin

C

Christian Drosten